Physicochemical Stability - Lipid Nanoparticles: Production, Characterization and Stability - page 93

Jia L, Shen J, Zhang D, Duan C, Liu G, Zheng D et al (2012) In vitro and in vivo evaluation
of oridonin-loaded long circulating nanostructured lipid carriers. Int J Biol Macromol
50(3):523-529
Joshi M, Müller R (2009) Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm
Biopharm 71(2):161-172
Kim C-J (2004) Surface chemistry and colloids. Advanced pharmaceutics. CRC Press, Boca
Raton
Kovacevic A, Müller R, Savic S, Vuleta G, Keck C (2014) Solid lipid nanoparticles (SLN) stabi-
lized with polyhydroxy surfactants: preparation, characterization and physical stability inves-
tigation. Colloid Surf A 444:15-25
Kovacevic A, Savic S, Vuleta G, Müller R, Keck C (2011) Polyhydroxy surfactants for the for-
mulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and parti-
cle matrix structure. Int J Pharm 406(1-2):163-172
Kumar S, Randhawa J (2013) Preparation and characterization of paliperidone loaded solid lipid
nanoparticles. Colloid Surf B 102:562-568
Lawler P, Dimick P (2002) Crystallization and polymorphism of fats. In: Akoh C, Min D (eds)
Food lipids: chemistry, nutrition and biotechnology. Marcel Dekker, New York, pp 275-300
Liu D, Ge Y, Tang Y, Yuan Y, Zhang Q, Li R et al (2010) Solid lipid nanoparticles for trans-
dermal delivery of diclofenac sodium: preparation, characterization and in vitro studies. J
Microencapsul 27(8):726-734
Liu D, Liu Z, Wang L, Zhang C, Zhang N (2011) Nanostructured lipid carriers as novel carrier
for parenteral delivery of docetaxel. Colloid Surf B 85(2):262-269
Liu J, Gong T, Fu H, Wang C, Wang X, Chen Q et al (2008) Solid lipid nanoparticles for pulmo-
nary delivery of insulin. Int J Pharm 356(1-2):333-344
Lukowski G, Kasbohm J, Pflegel P, Illing A, Wulff H (2000) Crystallographic investigation of
cetylpalmitate solid lipid nanoparticles. Int J Pharm 196(2):201-205
Mengersen F, Bunjes H (2012) Chemical stability of phospholipid-stabilized supercooled smectic
cholesteryl myristate nanoparticle. Eur J Pharm Biopharm 82(2):262-271
Mitri K, Shegokar R, Gohla S, Anselmi C, Müller R (2011) Lipid nanocarriers for dermal
delivery of lutein: Preparation, characterization, stability and performance. Int J Pharm
414(1-2):267-275
Muchow M, Maincent P, Müller R (2008) Lipid nanoparticles with a solid matrix (SLN®,
NLC®, LDC®) for oral drug delivery. Drug Dev Ind Pharm 34(12):1394-1405
Müller R, Freitas C, zur Mühlen A, Mehnert W (1996) Solid lipid nanoparticles (SLN) for con-
trolled drug delivery. Eur J Pharm Sci 4(Suppl 1(0)):S75
Müller R, Keck C (2004) Challenges and solutions for the delivery of biotech drugs—a review of
drug nanocrystal technology and lipid nanoparticles. J Biotechnol 113(1-3):151-170
Müller R, Radtke M, Wissing S (2002) Solid lipid nanoparticles (SLN) and nanostructured
lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliver Rev
54:S131-S155
Nik A, Langmaid S, Wright A (2012) Nonionic surfactant and interfacial structure impact
crystallinity and stability of β -carotene loaded lipid nanodispersions. J Agric Food Chem
60(16):4126-4135
Nutan M, Reddy I (2009) General Principles of Suspensions. In: Kulshreshtha A, Singh O, Wall
G (eds) Pharmaceutical suspensions—from pharmaceutical development to manufacturing.
Springer, New York
Ohki S, Ohshima H (1999) Interaction and aggregation of lipid vesicles (DLVO theory versus
modified DLVO theory). Colloid Surf B 14(1-4):27-45
Ohshima H, Miyagishima A, Kurita T, Makino Y, Iwao Y, Sonobe T et al (2009) Freeze-dried
nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution.
Int J Pharm 377(1-2):180-184
Rabinow B (2004) Nanosuspensions in drug delivery. Nat Rev Drug Discovery 3(9):785-796